Researchers in Russia and the United States have discovered the structure of the BLT1 leukotriene receptor, which is involved in inflammatory processes and plays a role in the development of infectious, allergic, and oncological diseases. A respective study published in the journal Nature Communications paves the way for new treatments for type 2 diabetes.
Researchers have found out that BLT1 is linked to a number of diseases, including asthma, influenza, arthritis, atherosclerosis, diabetes, and even cancer.
They have tried many times to use the receptor as a target for drugs, but the potential drugs had a number of undesirable side effects, their effectiveness was very low, and it took a long time to get them out of the body.
The authors of the aforesaid study have intr